AviadoBio Targets Rare Form Of Dementia With Gene Therapy

With Targeted Thalamus Delivery

The UK biotech hopes to address a fast-progressing form of dementia that affects people earlier in life with a supplemental gene therapy delivered directly to the brain’s information centre.  

EPC AviadoBio
Frontotemporal Dementia Causes Cognitive, Speech And Behavioral Decline • Source: Shutterstock

More from Emerging Company Profiles

More from Start-Ups & SMEs